Design and Rationale of Targeted Therapy With a Sirolimus-Eluting, Biodegradable Polymer Coronary Stent in Chronic Total Occlusions (TARGET CTO): A Multicenter, Open-Label, Randomized Noninferiority Trial
采用西罗莫司洗脱生物可降解聚合物冠状动脉支架治疗慢性完全闭塞病变的靶向治疗的设计和原理（TARGET CTO）：一项多中心、开放标签、随机非劣效性试验
期刊:
影响因子:
doi:10.1016/j.jscai.2022.100511
Han, Yaling; Wang, Geng; Li, Yi; Zheng, Ming; Cao, Ruifen; Zhang, Ruiyan; Chen, Shaoliang; Wang, Jian'an; Ma, Yitong; Sun, Zhiqi; Li, Xueqi; Su, Xi; Lu, Wen; Xu, Yawei; Spitzer, Ernest; Li, Xue; Sun, Fucheng
